Abstract
Purpose
Regarding in vivo, robust longitudinal relaxation rate (R 1) mapping, the goal of the present paper is two‐fold. First, to verify that non‐bijective mapping in magnetization‐prepared 2 rapid gradient echo (MP2RAGE) imaging can be resolved through a two‐dimensional look‐up table approach. Second, that the expanded parameter space from this can be used to improve ‐inhomogeneity tolerance without other prerequisites.
Theory
By deriving a second contrast from the magnitude images of the MP2RAGE acquisition, ambiguities in the original MP2RAGE image resulting from non‐bijective transfer curves can be resolved. Such ambiguities may occur when protocols are optimized, such as for higher ‐inhomogeneity tolerance. A 2D look‐up table approach combines the available information to resolve these ambiguities during mapping.
Methods
At 3 T, we acquired MP2RAGE images with standard acquisition parameters and (non‐bijective) parameters optimized for ‐inhomogeneity tolerance. From 3 subjects across multiple sessions, we assessed the ‐inhomogeneity tolerance through excitation‐pulse amplitude scalings.
Results
The R 1 maps resulting from the ‐optimized protocols showed greatly reduced effects across images but without additional scanner time. Meanwhile, these maps could only successfully be derived by a 2D look‐up table approach.
Conclusion
We show that it is possible to optimize for ‐inhomogeneity tolerance in MP2RAGE through sequence‐parameter settings, while still successfully estimating the R 1 map with a two‐dimensional look‐up table approach. This without the need for an additional map. The increased parameter space enabled by the two‐dimensional look‐up table approach may further be used to adjust MP2RAGE acquisitions for improved scan times, signal‐to‐noise ratio, and/or contrast‐to‐noise ratio.
Keywords: 2D look‐up table, B1+ inhomogeneity, MP2RAGE, non‐bijective data, R 1‐mapping
1. INTRODUCTION
In order for longitudinal relaxation rate (R 1) mapping to achieve subject‐specific, in vivo, detailed maps of human cortical structures (building on Refs. 1, 2, 3), it is important that R 1 changes reflect variations in myelo‐architecture rather than contaminations from artifacts. To map structurally distinct cortical areas beyond primary sensory tissue 1 , 2 , 3 (i.e., whole‐brain), highly refined images are required. To detect subtle variations, these images need to be detailed and reliable (i.e., have high resolution and minimal artifact contributions). One prominent source of artifacts is inhomogeneity, which modulates the flip angle (FA), and consequently the measured signal. Factors that affect the size of effects include B 0, readout train length, and repetition time (T R). The result is that, as higher resolutions become possible, artifacts increasingly counteract the benefits of increased spatial detail. Methodological strategies are necessary to limit the loss in R 1 specificity as increased resolutions are achieved.
Magnetization‐prepared 2 rapid gradient echo (MP2RAGE) is a T 1‐weighted MRI sequence that produces quantitative maps, while designed to mitigate B 1 effects. 4 By acquiring two rapid gradient echoes, and by combining these during postprocessing into a unified MP2RAGE image, , B 0, and B 1 − effects can be eliminated. Calibrating sequence parameters, like the FAs or inversion times, can further minimize the effects, thereby reducing the need for map–based correction during postprocessing. 5 Avoiding additional acquisition and correction steps minimizes scan times and accumulation of errors. Novel parallel‐transmit techniques additionally address effects during acquisition, 6 , 7 , 8 , 9 , 10 although accessible implementations leave residual inhomogeneities. 9 In certain situations, such as with increased number of slices, these residual inhomogeneities will leave severe bias in the resulting R 1 maps.
Because MP2RAGE images are quantitative, the image values can be derived from T 1 and the sequence parameters via Bloch simulations. If the mapping is bijective (i.e., one‐to‐one), then each MP2RAGE value can be uniquely associated with a T 1 value. 11 However, parameters with desirable features, including improved tolerance to inhomogeneities, high within‐tissue or between‐tissue contrast, or faster scanning times, may produce mappings that are non‐bijective. Consequently, R 1 values are misestimated, and a different strategy is required to successfully derive R 1 maps.
In this paper, we investigate the possibility of mitigating effects with modified sequence parameters by tackling the challenge of non‐bijective mappings between MP2RAGE values and R 1. To this end, we introduce a new strategy able to derive R 1 maps from MP2RAGE acquisitions with non‐bijective mappings. The present R 1 mapping uses a secondary contrast, derived from the MP2RAGE acquisition, based on the ratio between the difference and the sum of the magnitude of the two gradient‐echo images (difference‐sum‐ratio [DSR]). Similar to the MP2RAGE image, effects related to , B 0, and B 1 − are canceled out in the DSR image. Additionally, the DSR contrast is suitable for disambiguation of MP2RAGE values. Consequently, accurate R 1 maps can be determined for non‐bijective mappings, as may be the case in protocols highly tolerant of inhomogeneity.
2. THEORY
Quantitative T 1‐weighted images are derived from the MP2RAGE acquisition by combining the gradient‐echo images () acquired from each inversion time (), voxel by voxel, into a unified image (I UNI), as follows:
| (1) |
When nuisance factors contribute equally to I 1 and I 2, these effects cancel out in I UNI. By nature of Eq. (1), I UNI values are bound between −0.5 and + 0.5, and exactly equal to ±0.5, when I 1 = ±I 2. Because these values are quantitative, I UNI values can be derived from T 1 or R 1(=1/T 1). In standard implementations, I UNI is mapped to R 1 values via a one‐dimensional look‐up table (1D‐LUT), which can be visualized by a transfer curve (see Figure 1). A bijective relationship between I UNI and R 1 is required for the 1D‐LUT procedure to be applicable. This is achieved by careful selection of sequence parameters (Figure 1A). 4 By scaling the FAs, the effects of inhomogeneity on estimated R 1 values can be derived and visualized as separate transfer curves.
FIGURE 1.

The magnetization‐prepared rapid gradient echo–to‐T 1 transfer curves for the Standard (A) and LessBias (B) protocols, with corresponding R 1 values on the right axis. The Standard protocol is more sensitive to inhomogeneities than the LessBias protocol, which is almost insensitive to variations in the order of 40%. Within the range of T 1 values from 0 s to 5 s, the Standard protocol has a near‐bijective relationship between the MP2RAGE uniform‐image (UNI) values and T 1; this is not the case for the LessBias protocol, where within the T 1 window, there are ambiguous UNI values. Also notice, we maintain a near identical contrast between gray matter (GM) and white matter (WM). CSF, cerebrospinal fluid.
It is possible to select sequence parameters in which the corresponding transfer curve results in less dependency on variations (Figure 1B). However, such parameters may lead to non‐bijective mapping within the R 1 window of interest. Here, the 1D‐LUT method fails, because R 1 values from two different tissue types (e.g., gray matter [GM] and cerebrospinal fluid [CSF]) map to the same I UNI value. These non‐bijections will occur when I 1 = ±I 2 at any point within the R 1 window of interest. For standard protocols, non‐bijection will typically occur for low R 1s (⪅ 0.2 s−1), leading to large R 1 variance within CSF, which is normally unproblematic (however, see Section 5). For mappings in which the non‐bijection occurs at relatively high R 1 values (like in Figure 1B), a solution is needed (see Supporting Information Section 3).
By introducing a second, distinct contrast that is derived from I 1 and I 2, we are able to solve ambiguities in non‐bijective mappings and accurately estimate the R 1 values. This second contrast can be defined in several ways. We settled on a combination of the magnitudes of I 1 and I 2, as these magnitude images are readily available in standard setups. Similar to I UNI, we further wanted this contrast to be quantitative and tolerant to magnetic field inhomogeneities. The ratio between the difference of the first and second magnitude values and the sum (I DSR) satisfies these requirements, as follows:
| (2) |
Multiplying the denominator by 2 ensures that I DSR values fall within the same range as the I UNI values. As I DSR equals ±0.5 when either |I 1| or |I 2| is 0, and I DSR equals 0 where |I 1| = |I 2|, the I DSR contrast is indeed distinct from I UNI, where this behavior is inverted. Similar to I UNI, nuisance factors contributing equally to |I 1| and |I 2| are canceled out in I DSR.
Successful non‐bijective mapping is performed by using a two‐dimensional lookup table (2D‐LUT), connecting a pair of (I UNI, I DSR) values to their corresponding R 1 value, henceforth referred to as 2D‐LUT‐MP2RAGE. In its simplest implementation, the 2D‐LUT procedure compares the Euclidean distance between measured and reference value pairs to obtain the R 1 value (here pdist2 in MATLAB; The MathWorks, Inc., Natick, MA, USA); this is illustrated in Figure 2. To ensure that the R 1 estimation is driven by I UNI values, as is the case for 1D‐LUT, a larger weight can be applied to I UNI by equally scaling the measured and reference I UNI values.
FIGURE 2.

(A,B) One‐dimensional (1D) transfer curves for the magnetization‐prepared rapid gradient echo (MP2RAGE) uniform image (UNI; C) and difference‐sum‐ratio (DSR; D) of the LessBias protocol, respectively. (E,F) Resulting 1D and two‐dimensional (2D) lookup table (LUT) R 1 maps, respectively. (G) The 2D transfer curve among MP2RAGE UNI, DSR, and R 1. The MP2RAGE DSR (D) can be used to disentangle the ambiguous relationship between the MP2RAGE UNI image (C) and the R 1 value (A, B). The method is illustrated for cerebrospinal fluid (CSF; purple) and deep gray‐matter (GM; orange) voxels with MP2RAGE UNI values close to each other. By Identifying the MP2RAGE values in both the MP2RAGE UNI image and the MP2RAGE DSR image, a unique R 1 value can be assigned to each voxel using a 2D‐LUT (F) but not a 1D‐LUT (E). (G) The mapping is unambiguous in the full MP2RAGE UNI, DSR, and R 1 space.
3. METHODS
The purpose of the present study is two‐fold: first, to verify that R 1 mapping can be performed successfully in expanded sequence parameter space by resolving non‐bijective mapping through 2D‐LUT; and second, that from this expanded parameter space, parameters can be selected that result in R 1 maps unaffected by inhomogeneities to an extent unseen without non‐bijective mapping. To demonstrate our proposed method, we acquired experimental data in a total of seven session across 3 subjects (the authors; see Table S1) on a 3T PrismaFit system (Siemens Healthineers, Erlangen, Germany) using a 32‐channel receive‐only head coil. Images were acquired with the default configuration of the host site (Standard) and a new protocol (LessBias) with improved tolerance to inhomogeneities in the final R 1 maps: (1) Standard: T R ,MP2RAGE = 5 s, T R ,FLASH = 7.18 ms, FA1/FA2 = 4°/5°, T I,1/T I,2 = 700 ms/2500 ms; (2) LessBias: T R ,MP2RAGE = 5 s, T R ,FLASH = 7.18 ms, FA1/FA2 = 3°/5°, T I,1/T I,2 = 500 ms/1900 ms. In both cases, a single acquisition took 11:20 min with a 215.6 × 172.8 × 230 mm3 field of view (anterior–posterior/left–right/superior–inferior; phase/slice/read), grid size = 256 × 192 × 240 (i.e., 0.9‐mm3 isotropic voxels, partial Fourier = 6/8, and 2xGRAPPA). 12 FatNavs motion correction was applied. 13 , 14 To systematically modify variation, we modified the excitation pulse amplitude (“SRFExcit” in the scan card; Figure S1), which is equivalent to using noninteger FAs. Each protocol was acquired 3 times, with SRFExcit at 60%, 100%, and 140% (i.e., FA1/FA2 = 2.4°/3° for Standard‐60%) of the reference voltage. This range reflects the inhomogeneities seen beyond 3 T, allowing us to get an indication on how it would fare at higher field strengths, such as at 7 T, 4 and fully stress‐test the 2D‐LUT‐MP2RAGE at 3 T.
Following FatNavs motion correction, 13 , 14 the anterior and posterior commissure were identified on the Standard 100% excitation‐pulse amplitude image. Next, all other images were reoriented accordingly, to obtain a near–anterior and posterior commissure space orientation in all acquisitions. For each acquisition, an R 1 map was created using 1D‐LUT 11 and 2D‐LUT for Standard and LessBias acquisitions, respectively.
The 2D‐LUT R 1 mapping was performed using a step size of ΔR 1 = 0.001 s−1 from R 1 = 0.01 s−1 to 20 s−1. These hyperparameters were chosen empirically to avoid 2D‐LUT truncation effects. We opted for equidistant R 1 spacing over equidistant T 1 spacing, to better capture variations in the WM‐GM range. To compare 1D‐LUT and 2D‐LUT R 1 mapping most directly, we applied a strong, empirically determined 100:1 weight ratio between I UNI and I DSR before calculating the Euclidian distance. Consequently, R 1 values were assigned on the basis of the I UNI values, with I DSR values used primarily for disambiguation.
The resultant R 1 maps were segmented using SPM12 r7711, 15 , 16 and from the segmented images, two masked R 1 maps were created. The first masked image was constructed from a one‐step eroded brain mask containing voxels where the sum of posterior probabilities for CSF, GM, and WM exceeded 0.2. The second was constructed similarly, but included skull and soft tissue voxels. The brain‐only R 1 maps were coregistered to the Standard 100% excitation‐pulse amplitude acquisition, and the estimated registrations were applied to all images. From these brain‐masked, coregistered R 1 maps, mean and standard deviation maps across the different excitation‐pulse amplitude scalings for both protocols (Standard and LessBias) were calculated. These mean and standard deviation maps were used to assess the standard deviation within each tissue type and visualize the effects in WM and CSF.
The effects within GM were visualized on a central GM surface. Central GM surfaces were constructed using CAT12 r2560 17 , 18 , 19 , 20 to segment the head‐masked, coregistered R 1 maps with the iso‐volume approach. 21 , 22 By sampling each R 1 map on their corresponding central GM surface and projecting out the local curvature, 1 we obtained curvature‐corrected central GM R 1 surfaces for each image. Before curvature correction, both curvature and R 1 surfaces were resampled to the FreeSurfer template surface in CAT12, and 2D‐smoothed with a Gaussian kernel (full width at half maximum = 6 mm). From these surfaces, we calculated the standard deviation across the different excitation‐pulse amplitude scalings, for both protocols. The curvature‐corrected R 1 values and their standard deviations were then visualized on an inflated GM template surface.
To compare the effects of noise and inhomogeneity on R 1, we acquired three images for both protocols in 1 subject with unmanipulated excitation pulses. Instead, the nominal FA provided during R 1 mapping was manipulated in steps of 10%. Ten R 1 maps were derived for each image, where the FA for one image was left untouched; the FA for one image was reduced by 0% to 90%; and the FA in the last image was increased by 0% to 90%. Preprocessing of these images was left as described previously.
In addition, we acquired SA2RAGE images during each session to compare the efficacy of LessBias against postprocessing ‐map correction. 5 correction was applied to the Standard images using in‐house code (see Supporting Information Section 7), and the corrected R 1 maps were compared with both uncorrected Standard and LessBias R 1 maps (see Supporting Figures S11–S15).
4. RESULTS
The signal‐to‐noise ratio (SNR) between Standard and LessBias is highly comparable for nominal excitation FAs (i.e., SRFExcit of 100%). When SNR is defined as the maximum intensity value across |I 1| and |I 2| divided by the mean intensity value of the background of |I 1|, SNRStandard ≈ 75 and SNRLessBias ≈ 71.
Figure 1 shows the transfer curves of Standard (1A) and LessBias (1B), the latter showing non‐bijection within the R 1 window of interest (0.2–5 s−1), with the fold occurring at approximately R 1 = 0.4 s−1. Additionally, the estimated inhomogeneity tolerance in the GM and WM range for LessBias is strongly improved compared with Standard. Figure 2 visualizes the 2D‐LUT‐MP2RAGE. Figure 2E shows how the 1D‐LUT approach gives rise to ambiguous R 1 values across CSF (purple square) and GM (orange square). Figure 2F shows how 2D‐LUT resolves the non‐bijective mapping.
Figures 3 and 4 outline the results of amplifying across acquisitions. In Figure 3, substantial WM R 1 variation is seen across the different levels of amplification in Standard for Subjects 1–3. In contrast, LessBias combined with 2D‐LUT provide consistent WM R 1 values across amplifications. For a detailed overview of the standard deviations across protocols, see Tables S5–S7.
FIGURE 3.

Volumetric R 1 maps from the Standard (odd rows) and LessBias (even rows) protocol for Subject 1 (top), 2 (middle), and 3 (bottom). By scaling the excitation pulse amplitude to 60%, 100%, and 140% (Columns 1–3, respectively), it is possible to visualize the benefit of the LessBias protocol. As shown from both the individual acquisitions and the standard deviation image (Column 4), the LessBias protocol does indeed, as predicted from Figure 1, demonstrate robustness to deviations from the nominal . From the standard deviation images, it can be observed that LessBias provides a strongly reduced standard deviation for gray matter and white matter, at the cost of a slightly increased standard deviation for cerebrospinal fluid, compared with the Standard protocol. Actual mean and standard deviation of R 1 values are listed in Table S6.
FIGURE 4.

Gray‐matter (GM) surface R 1 maps from the Standard (odd rows) and LessBias (even rows) protocol for Subject 1 (top), 2 (middle), and 3 (bottom). GM surfaces are presented with uniform windowing across images (0.65–0.85 s−1). By scaling the excitation pulse amplitude to 60%, 100%, and 140% (Columns 1–3, respectively), it is possible to visualize the benefit of the LessBias protocol. As shown from both the individual acquisitions and the standard deviation surface (Column 4), the LessBias protocol does indeed, as predicted from Figure 1, demonstrate robustness to deviations from the nominal . From the standard deviation surfaces, it appears that LessBias provides a strongly reduced standard deviation for GM, compared with the Standard protocol. Increased R 1 values are observed in expected regions (V1, M1, S1, A1, and possibly V5). Cortical GM volume and thickness estimations are listed in Table S3. Actual mean and standard deviation of R 1 values are listed in Table S6.
In Figure 4, the variability in R 1 values is displayed on central GM surfaces across Subjects 1–3. Standard (odd rows) shows substantial variation in R 1 values compared with LessBias (even rows). This is further illustrated by the standard deviation across each row (final column), where the standard deviations for LessBias are consistently substantially lower than for Standard. Highly myelinated areas (e.g., V1/V5‐MT+/M1/S1/A1 1 , 2 , 3 ) are reliably identifiable across LessBias images, whereas they become less distinct in Standard (e.g., V1 in Subject 1–Standard 140% or Subject 3–Standard 60%).
Figure 5 shows the results of manipulating the nominal FA during R 1 mapping across comparable images from one session. At an FA manipulation of ±0%, we expect the variance across images to be driven primarily by noise. Differences in standard deviation at ±0% and the FA manipulations indicate the contribution of bias.
FIGURE 5.

(A) R 1 standard deviation maps of Standard for flip‐angle (FA) manipulations performed during R 1 map estimation. (B) R 1 standard deviation maps of LessBias for FA manipulations performed during R 1‐map estimation. (C) Distributions of voxel‐wise R 1 standard deviations per manipulation for Standard and LessBias (in color and grayscale, respectively). For each tissue type (gray matter [GM], white matter [WM], and cerebrospinal fluid [CSF]), a mask was created from the intersections between Standard and LessBias of the segmented volumes from the unmanipulated (: 100%) Standard and LessBias images. (D) Mean of the standard deviations distributions of (C) for GM, WM, and CSF plotted against each other per manipulation. The leftmost/rightmost points belong to 0% and 90% manipulation, respectively. We expect that variation seen in (A) and (B) at ±0% is primarily driven by noise. Variation introduced as a result of the FA manipulation is assumed to be analogue to bias‐induced variation. Visually, it appears in (A) that bias overtakes as the driving factor for variation at ±20%. This is confirmed by the histograms in (C), where especially in GM and WM, the distribution of standard deviations appears to be a linear shift based on the FA manipulation. This becomes more apparent where we see that the contribution of an FA manipulation of 20% and above greatly outweighs the contribution of a ±10% manipulation. Meanwhile, visual variation in LessBias for WM and especially GM remains minimal for a far higher FA manipulation, as seen in (B). Distribution of standard deviations as a result of the manipulation in (C) is far less spread out in GM and WM for LessBias than Standard. In (D), we see that the mean standard deviation in GM is increased by about 10% at a ±90% FA manipulation, and in WM about 20% at a ±40% FA manipulation (vs. ˜300% and ˜75% in Standard respectively).
The Supporting Information (overview in Table S1) further describes quantitative R 1 accuracy assessment with respect to curvature correction (Section 4), segmentation robustness (Section 5), mean R 1 values across subjects, protocols and sessions (Section 6), FatNavs effects (Section 6), and influence of number of slices (Sections 5 and 6).
5. DISCUSSION
With 2D‐LUT‐MP2RAGE R 1 mapping, we have expanded the MP2RAGE sequence parameter space, enabling us to further refine the features of MP2RAGE acquisitions. In this paper, we focused on the potential for improving ‐inhomogeneity tolerance on the path toward ultrahigh resolution. Given the push for higher field strengths, 23 , 24 driven by this desire for higher resolutions, the problem of ‐inhomogeneity intolerance will only become more pressing. To investigate levels of inhomogeneities similar to those seen at 7 T, we manipulated the amplitude of the excitation pulse across images. It appears indeed possible to achieve greatly improved ‐inhomogeneity tolerance with minimal SNR compromise. Using the adjusted sequence parameters in combination with 2D‐LUT mapping, we drastically reduced the standard deviation of WM and GM tissue volumes (see Tables S2–S4) and R 1 values (see Tables S5–S7) without extending the acquisition time. This further indicates that differences across manipulations are smaller for LessBias than Standard, confirming the former is more robust against effects.
Figure 5 shows that, for the Standard protocol, contributions to variance compared with noise are already substantial at ±20%. Meanwhile, Figure 5 suggests that LessBias is far less susceptible to effects in GM and WM, showing nearly no effect of bias in GM and a drastically reduced effect in WM compared with Standard. Similarly, variability in CSF is greatly reduced in LessBias up to a point, showing a shift at about 40%. This shift could be because the analysis captures consistency, not accuracy. Beyond a certain FA manipulation, variability may top out, slowing down the trajectory of Standard. It should also be noted that the SNR during each manipulation remains constant, whereas variations in the FA during acquisition would result in altered SNRs. As a result, Figure 5 cannot catch the total effect of inhomogeneities, but only the variation driven by deviations from the nominal transfer curve.
There are alternative methods that correct for either in postprocessing 25 , 26 (e.g., SA2RAGE 5 or MP3RAGE 27 ) or at the acquisition stage, (e.g., parallel transmission 6 , 7 and universal pulses). 8 , 9 , 10 For example, parallel‐transmit PASTeUR universal pulses substantially reduced inhomogeneities at 7 T compared with circular polarization mode. 9 The remaining inhomogeneity should be manageable with 2D‐LUT‐MP2RAGE. Note that the parameters used in the protocol can be adjusted to the user's needs but at the expense of other parameters. For instance, the number of slices can be increased for higher resolution imaging, but maintaining ‐inhomogeneity tolerance requires additional adjusting of inversion times and FAs. The extent of these adjustments would further depend on what other inhomogeneity–compensation techniques are available and the B 0 (for an example, see Supporting Information Section 8).
Whether or not MP2RAGE is acquired in combination with, for example, universal pulses, we see no immediate downsides of using 2D‐LUT‐MP2RAGE, given that the potential benefits come at virtually no cost compared with standard MP2RAGE applications.
LessBias, made possible with 2D‐LUT‐MP2RAGE, provides ‐inhomogeneity tolerance at the voxel level without modified sequences or increased scan times, and with sufficient time for fat navigators. Time otherwise needed for such high‐resolution ‐inhomogeneity corrections can instead be used to improve throughput, SNR, or resolution of R 1 images. Given that the LessBias protocol is agnostic to hardware setup and availability of secondary sequences, we anticipate that it can be implemented to tackle the challenges of cross‐site collaborations 28 to a larger extent than alternative methods.
Recent developments with synthetic T 1 contrasts showed that through a sufficiently accurate T 1 map, different T 1‐weighted contrasts can be derived in postprocessing, and that this can be used to optimize scan times. 8 When relying on synthetic MRI, the contrast of the original acquisition can be arbitrary, as long as the T 1 mapping succeeds. This means that I UNI no longer needs to be visually interpretable and permits non‐bijection. Consequently, further optimizations for improved ‐inhomogeneity tolerance, SNR, and/or acquisition times may be possible in the wider sequence parameter space. Desired (visually interpretable) contrasts can then be computed from the resultant T 1 maps.
Other implementations for non‐bijective transfer curves may be for specialized uses (e.g., Ref. 29). Such cases may require sequence parameters that come with increased contrast‐to‐noise ratio in or across specific tissues (e.g., simultaneous brain and cervical spinal cord imaging). Reducing the slope of the transfer curve will not only lead to increased contrast between tissues in I UNI but will also lead to non‐bijective transfer curves when the slope drops below a certain threshold. When such protocols are desired, 2D‐LUT‐MP2RAGE will still be able to derive accurate R 1 maps from the data. Through additional postprocessing steps, the high contrast from the original images could be extracted, whereas the R 1 map serves as a reference.
The remaining CSF T 1‐variance compromise impose limits such as in specific CSF‐based MRI biomarkers and neurodegenerative‐disease studies. 30 However, we stress that Standard suffered from stronger variance than LessBias. Through 2D‐LUT‐MP2RAGE, it may be possible to select parameters that address T 1 variance in CSF, but this was not investigated. Additionally, Standard suffers from non‐bijections around CSF at a low , leading to larger misestimations in 1D‐LUT that cannot be corrected with a 1D‐LUT ‐correction method.
This study assumed 96% inversion efficiency, 4 which anticipatedly is fairly valid at 3 T. There is evidence that at ultrahigh field strength this assumption is compromised, 27 and investigations with respect to inversion efficiency and our method remain. This is where 2D‐LUT‐MP2RAGE may best be combined with universal pulses.
Our maps (see Figure S16) show an expected ±20% variation, but we stress‐tested our method with ±40% excitation‐pulse amplitude scalings to mimic variations seen commonly at 7 T 4 as a feasibility test for future studies. This study does not directly answer how more severe variations are attacked, but as mentioned previously, we expect the method to add value in concert with other methods, such as using universal pulses. 9 , 10
6. CONCLUSIONS
With the 2D‐LUT‐MP2RAGE, we were able to open up the usable MP2RAGE acquisition parameter space, which can impart non‐bijective MP2RAGE‐to‐T 1 transfer curves. This increased freedom was used to address inhomogeneity without additional hardware or data than what the current MP2RAGE sequence inherently provides. Compared with typical MP2RAGE acquisition parameters, we saw greatly reduced variability across GM and WM R 1 values with variations (±40%). Although this paper focused on improving ‐inhomogeneity tolerance, this 2D‐LUT mapping may also enable the use of protocols that provide contrast or scan times previously unseen in MP2RAGE.
Supporting information
Data S1 Supporting information.
ACKNOWLEDGMENTS
M.S.V. received support from the Lundbeck Foundation. M.S.V. and L.R. received support from Familien Andresens selskab til fremme af medicinsk forskning. The authors thank Daniel Gallichan for providing access to the FatNavs‐MP2RAGE sequence.
Ruijters L, Lund TE, Vinding MS. Improving ‐inhomogeneity tolerance by resolving non‐bijection in MP2RAGE R 1 mapping: A 2D look‐up table approach demonstrated at 3 T . Magn Reson Med. 2025;93:1712‐1722. doi: 10.1002/mrm.30363
DATA AVAILABILITY STATEMENT
Code and example data set are available at https://github.com/torbenelund/2D‐lookup‐tools‐for‐MP2RAGE.
REFERENCES
- 1. Lutti A, Dick F, Sereno MI, Weiskopf N. Using high‐resolution quantitative mapping of R1 as an index of cortical myelination. Neuroimage. 2014;93:176‐188. doi: 10.1016/j.neuroimage.2013.06.005 [DOI] [PubMed] [Google Scholar]
- 2. Dick F, Taylor Tierney A, Lutti A, Josephs O, Sereno MI, Weiskopf N. In vivo functional and myeloarchitectonic mapping of human primary auditory areas. J Neurosci. 2012;32:16095‐16105. doi: 10.1523/JNEUROSCI.1712-12.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Glasser MF, Van Essen DC. Mapping human cortical areas in vivo based on myelin content as revealed by T1‐ and T2‐weighted MRI. J Neurosci. 2011;31:11597‐11616. doi: 10.1523/JNEUROSCI.2180-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias‐field corrected sequence for improved segmentation and T1‐mapping at high field. Neuroimage. 2010;49:1271‐1281. doi: 10.1016/j.neuroimage.2009.10.002 [DOI] [PubMed] [Google Scholar]
- 5. Eggenschwiler F, Kober T, Magill AW, Gruetter R, Marques JP. SA2RAGE: a new sequence for fast −mapping. Magn Reson Med. 2012;67:1609‐1619. doi: 10.1002/mrm.23145 [DOI] [PubMed] [Google Scholar]
- 6. Zhu Y. Parallel excitation with an array of transmit coils. Magn Reson Med. 2004;51:775‐784. doi: 10.1002/mrm.20011 [DOI] [PubMed] [Google Scholar]
- 7. Katscher U, Börnert P, Leussler C, van den Brink JS. Transmit SENSE. Magn Reson Med. 2003;49:144‐150. doi: 10.1002/mrm.10353 [DOI] [PubMed] [Google Scholar]
- 8. Bapst B, Massire A, Mauconduit F, et al. Pushing mp2rage boundaries: ultimate time‐efficient parameterization combined with exhaustive t 1 synthetic contrasts. Magn Reson Med. 2024;91:1608‐1624. doi: 10.1002/mrm.29948 [DOI] [PubMed] [Google Scholar]
- 9. Mauconduit F, Massire A, Gras V, Amadon A, Vignaud A, Boulant N. PASTeUR package extension with MP2RAGE for robust T1 mapping technique in parallel transmit at 7T. Proceeding of the 2020 ISMRM & SMRT Virtual Conference & Exhibition. International Society for Magnetic Resonance in Medicine and International Society for MR Radiographers & Technologists; 2020:3709. [Google Scholar]
- 10. Mauconduit F, Diraison T, Massire A, et al. Pushing the image quality by integrating FatNav and pTx universal pulses in MPRAGE and MP2RAGE sequences at 7T. In: Proceedings of the 2024 ISMRM & SMRT Virtual Conference & Exhibition. International Society for Magnetic Resonance in Medicine and International Society for MR Radiographers & Technologists; 2024. p. 4895. [Google Scholar]
- 11. Marques JP. MP2RAGE scripts. https://github.com/JosePMarques/MP2RAGE‐related‐scripts. Accessed April 5, 2024.
- 12. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202‐1210. doi: 10.1002/mrm.10171 [DOI] [PubMed] [Google Scholar]
- 13. Gallichan D, Marques JP, Gruetter R. Retrospective correction of involuntary microscopic head movement using highly accelerated fat image navigators (3D FatNavs) at 7T. Magn Reson Med. 2016;75:1030‐1039. doi: 10.1002/mrm.25670 [DOI] [PubMed] [Google Scholar]
- 14. Gallichan D. Retro‐MoCo‐Box. https://github.com/dgallichan/retroMoCoBox. Accessed April 5, 2024.
- 15. Friston K, Ashburner J, Kiebel S, Nichols T, Penny W, eds. Statistical Parametric Mapping. UK: Academic Press; 2007:625–647. doi: 10.1016/B978-012372560-8/50050-4 [DOI] [Google Scholar]
- 16. The University College London . SPM (Statistical Parametric Mapping). 2020. https://www.fil.ion.ucl.ac.uk/spm‐statistical‐parametric‐mapping/. Accessed April 5, 2024.
- 17. Gaser C, Dahnke R, Thompson PM, Kurth F, Luders E. Alzheimer's disease neuroimaging initiative. CAT: a computational anatomy toolbox for the analysis of structural MRI data. GigaScience. 2024;13. doi: 10.1093/gigascience/giae049 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Yotter RA, Dahnke R, Thompson PM, Gaser C. Topological correction of brain surface meshes using spherical harmonics. Hum Brain Mapp. 2011;32:1109‐1124. doi: 10.1002/hbm.21095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Dahnke R, Yotter RA, Gaser C. Cortical thickness and central surface estimation. Neuroimage. 2013;65:336‐348. doi: 10.1016/j.neuroimage.2012.09.050 [DOI] [PubMed] [Google Scholar]
- 20. Computational Anatomy Toolbox CAT12. https://neuro‐jena.github.io/cat12‐help/. Accessed April 8, 2024.
- 21. Consolini J, Demirci N, Fulwider A, Hutsler JJ, Holland MA. Bok's equi‐volume principle: translation, historical context, and a modern perspective. Brain Multiphys. 2022;3:100057. doi: 10.1016/j.brain.2022.100057 [DOI] [Google Scholar]
- 22. Dinse J, Härtwich N, Waehnert MD, et al. A cytoarchitecture‐driven myelin model reveals area‐specific signatures in human primary and secondary areas using ultra‐high resolution in‐vivo brain MRI. Neuroimage. 2015;114:71‐87. doi: 10.1016/j.neuroimage.2015.04.023 [DOI] [PubMed] [Google Scholar]
- 23. NWO . The Dutch National 14 Tesla MRI Initiative in Medical Science (Dynamic). NWO. https://www.nwo.nl/en/projects/184036009. Accessed April 2, 2024. [Google Scholar]
- 24. U.S. Food and Drug FDA clears first 7T magnetic resonance imaging device, administration. https://www.fda.gov/news‐events/press‐announcements/fda‐clears‐first‐7t‐magnetic‐resonance‐imaging‐device. Accessed April 2, 2024.
- 25. Weiskopf N, Suckling J, Williams G, et al. Quantitative multi‐parameter mapping of R1, PD*, MT, and R2* at 3T: a multi‐center validation. Front Neurosci. 2013;7:95. doi: 10.3389/fnins.2013.00095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Marques JP, Gruetter R. New developments and applications of the MP2RAGE sequence—focusing the contrast and high spatial resolution R1 mapping. Yacoub E, ed. PLoS One. 2013;8:e69294. doi: 10.1371/journal.pone.0069294 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Olsson H, Andersen M, Kadhim M, Helms G. MP3RAGE: simultaneous mapping of T1 and in human brain at 7T. Magn Reson Med. 2022;87:2637‐2649. doi: 10.1002/mrm.29151 [DOI] [PubMed] [Google Scholar]
- 28. Haast RAM, Lau JC, Ivanov D, Menon RS, Uludağ K, Khan AR. Effects of MP2RAGE sensitivity on inter‐site T1 reproducibility and hippocampal morphometry at 7T. Neuroimage. 2021;224:117373. doi: 10.1016/j.neuroimage.2020.117373 [DOI] [PubMed] [Google Scholar]
- 29. Forodighasemabadi A, Rasoanandrianina H, El Mendili MM, Guye M, Callot V. An optimized MP2RAGE sequence for studying both brain and cervical spinal cord in a single acquisition at 3T. Magn Reson Imaging. 2021;84:18‐26. doi: 10.1016/j.mri.2021.08.011 [DOI] [PubMed] [Google Scholar]
- 30. Kaipainen A, Jääskeläinen O, Liu Y, et al. Cerebrospinal fluid and MRI biomarkers in neurodegenerative diseases: a retrospective memory clinic‐based study. J Alzheimers Dis. 2020;75:751‐765. doi: 10.3233/JAD-200175 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1 Supporting information.
Data Availability Statement
Code and example data set are available at https://github.com/torbenelund/2D‐lookup‐tools‐for‐MP2RAGE.
